News Releases Year None20242023202220212020201920182017 NuCana Announces First Patients Dosed in Phase I Study of NUC-7738 Jul 17, 2019 NuCana Receives Orphan Drug Designation from the U.S. Food and Drug Administration for Acelarin® for the Treatment of Biliary Tract Cancer Jun 12, 2019 NuCana to Present at the Jefferies 2019 Healthcare Conference May 30, 2019 NuCana Reports First Quarter 2019 Financial Results and Provides Business Update May 14, 2019 NuCana to Participate in the William Blair 3rd Late-Stage Therapeutics Conference Apr 02, 2019 NuCana Reports Fourth Quarter and Year-End 2018 Financial Results and Provides Business Update Mar 07, 2019 NuCana to Present at the Cowen and Company 39th Annual Health Care Conference Mar 05, 2019 NuCana to Present at the American Association for Cancer Research (AACR) Annual Meeting 2019 Feb 27, 2019 NuCana plc Announces Withdrawal of Public Offering of ADSs Jan 25, 2019 NuCana plc Announces Proposed Public Offering of ADSs Jan 23, 2019 Pagination First page « first Previous page ‹ previous … Page 6 Page 7 Page 8 Page 9 Page 10 Current page 11 Page 12 Page 13 Page 14 Next page next › Last page last »
NuCana Receives Orphan Drug Designation from the U.S. Food and Drug Administration for Acelarin® for the Treatment of Biliary Tract Cancer Jun 12, 2019
NuCana Reports Fourth Quarter and Year-End 2018 Financial Results and Provides Business Update Mar 07, 2019
NuCana to Present at the American Association for Cancer Research (AACR) Annual Meeting 2019 Feb 27, 2019